N-ACETYLPROCAINAMIDE ASSAY FOR THE BAYER IMMUNO 1 SYSTEM— 510(k) K971713

Name: FDA 510(k) clearance K971713
Creator: U.S. Food and Drug Administration
Published: 1997-06-11

Substantially Equivalent

Bayer Corp.

FDA 510(k) clearance K971713 for N-ACETYLPROCAINAMIDE ASSAY FOR THE BAYER IMMUNO 1 SYSTEM, Substantially Equivalent on 1997-06-11. Applicant: Bayer Corp.. Device class: 2.

Clearance details

Applicant: Bayer Corp.
Product code: Code LAN
Device class: Class 2
Regulation: 21 CFR 862.3320
Advisory panel: Clinical Toxicology
Date received: 1997-05-09
Decision date: 1997-06-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LAN

view all

K060738 — TDM N-ACETYLPROCAINAMIDE2006-08-16
K032564 — DIMENSION N-ACETYLPROCAINAMIDE (NAPA) FLEX REAGENT CARTRIDGE METHOD, MODEL DF1112003-10-31
K011620 — EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N2292001-06-18
K983812 — NAPA EIA ASSAY1998-11-16
K955422 — AXSYM N-ACETYLPROCAINAMIDE1996-04-24

More clearances from Bayer Corp.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.